Increased risk of melanoma in C9ORF72 repeat expansion carriers: A case-control study.
Miguel Tábuas-PereiraLuciano AlmendraMaria Rosário AlmeidaJoão DurãesAndré PinhoAnabela MatosLuis NegrãoArgemiro GeraldoIsabel SantanaPublished in: Muscle & nerve (2018)
These findings suggest that patients with a history of melanoma may have an increased probability of carrying a C9ORF72 repeat expansion. ALS or FTLD carriers of C9ORF72 should undergo surveillance for skin changes. Muscle Nerve 59:362-365, 2019.